{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T20:03:47Z","timestamp":1763755427936,"version":"3.45.0"},"reference-count":32,"publisher":"Oncology Nursing Society (ONS)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJON"],"published-print":{"date-parts":[[2015,12,1]]},"DOI":"10.1188\/15.cjon.e121-e125","type":"journal-article","created":{"date-parts":[[2015,11,19]],"date-time":"2015-11-19T10:20:24Z","timestamp":1447928424000},"page":"E121-E125","source":"Crossref","is-referenced-by-count":0,"title":["Von Hippel-Lindau: Current Evidence in Diagnosis, Treatment, and Nursing Implications"],"prefix":"10.1188","volume":"19","author":[{"given":"Kaifan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Barkley Jr.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1302","published-online":{"date-parts":[[2015,12,1]]},"reference":[{"doi-asserted-by":"crossref","unstructured":"Capitanio, J.F., Mazza, E., Motta, M., Mortini, P., & Reni, M. (2013). Mechanisms, indications and results of salvage systemic therapy for sporadic and von Hippel-Lindau related hemangioblastomas of the central nervous system. Critical Reviews in Oncology\/Hematology, 86, 69\u201384. doi:10.1016\/j.critrevonc.2012.10.001","key":"1","DOI":"10.1016\/j.critrevonc.2012.10.001"},{"doi-asserted-by":"crossref","unstructured":"Choyke, P.L., Glenn, G.M., Walther, M.M., Patronas, N.J., Linehan, W.M., & Zbar, B. (1995). Von Hippel-Lindau disease: Genetic, clinical, and imaging features. Radiology, 194, 629\u2013642. doi:10.1148\/radiology.194.3.7862955","key":"2","DOI":"10.1148\/radiology.194.3.7862955"},{"doi-asserted-by":"crossref","unstructured":"Damiano, V., Rosa, R., Formisano, L., Nappi, L., Gelardi, T., Marciano, R., . . . Tortora, G. (2013). Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumor growth and angiogenesis. British Journal of Cancer, 108, 1616\u20131623. doi:10.1038\/bjc.2013.153","key":"3","DOI":"10.1038\/bjc.2013.153"},{"unstructured":"Frantzen, C., Klasson, T.D., Links, T.P., & Giles, R.H. (2015). Von Hippel-Lindau syndrome. GeneReviews. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1463","key":"4"},{"doi-asserted-by":"crossref","unstructured":"Friedrich, C.A. (2001). Genotype-phenotype correlation in von Hippel-Lindau syndrome. Human Molecular Genetics, 10, 763\u2013767. doi:10.1093\/hmg\/10.7.763","key":"5","DOI":"10.1093\/hmg\/10.7.763"},{"doi-asserted-by":"crossref","unstructured":"Hanakita, S., Koga, T., Shin, M., Takayanagi, S., Mukasa, A., Tago, M., . . . Saito, N. (2014). The long-term outcomes of radiosurgery for intracranial hemangioblastomas. Neuro-Oncology, 16, 429\u2013433. doi:10.1093\/neuonc\/not201","key":"6","DOI":"10.1093\/neuonc\/not201"},{"doi-asserted-by":"crossref","unstructured":"Hoebeeck, J., van der Luijt, R., Poppe, B., De Smet, E., Yigit, N., Claes, K., . . . Vandesompele, J. (2005). Rapid detection of VHL exon deletions using real-time quantitative PCR. Laboratory Investigation, 85, 24\u201333. doi:10.1038\/labinvest.3700209","key":"7","DOI":"10.1038\/labinvest.3700209"},{"doi-asserted-by":"crossref","unstructured":"Igarashi, H., Ito, T., Nishimori, I., Tamura, K., Yamasaki, I., Tanaka, M., & Shuin, T. (2014). Pancreatic involvement in Japanese patients with von Hippel-Lindau disease: Results of a nationwide survey. Journal of Gastroenterology, 49, 511\u2013516. doi:10.1007\/s00535-013-0794-1","key":"8","DOI":"10.1007\/s00535-013-0794-1"},{"unstructured":"Inglese, M. (2007). Von Hippel-Lindau disease: An overview. Nephrology Nursing Journal, 34, 390\u2013394.","key":"9"},{"doi-asserted-by":"crossref","unstructured":"Joly, D., M\u00e9jean, A., Corr\u00e9as, J.M., Timsit, M.O., Verkarre, V., Deveaux, S., . . . Richard, S. (2011). Progress in nephron sparing therapy for renal cell carcinoma and von Hippel-Lindau disease. Journal of Urology, 185, 2056\u20132060. doi:10.1016\/j.juro.2011.02.007","key":"10","DOI":"10.1016\/j.juro.2011.02.007"},{"doi-asserted-by":"crossref","unstructured":"Kim, B.Y., Jonasch, E., & McCutcheon, I.E. (2012). Pazopanib therapy for cerebellar hemangioblastomas in von Hippel-Lindau disease: Case report. Targeted Oncology, 7, 145\u2013149. doi:10.1007\/s11523-012-0214-0","key":"11","DOI":"10.1007\/s11523-012-0214-0"},{"doi-asserted-by":"crossref","unstructured":"Knudson, A.G., Jr. (1986). Genetics of human cancer. Annual Review of Genetics, 20, 231\u2013251. doi:10.1146\/annurev.ge.20.120186.001311","key":"12","DOI":"10.1146\/annurev.ge.20.120186.001311"},{"unstructured":"Lambert, M., & Barkley, T.W., Jr. (2015). Pheochromocytoma. In T.W. Barkley, Jr., & C.M. Myers (Eds.), Practice considerations for adult-gerontology acute care nurse practitioner (pp. 620\u2013624). West Hollywood, CA: Barkley and Associates.","key":"13"},{"doi-asserted-by":"crossref","unstructured":"Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F.M., Orcutt, M.L., . . . Geil, L. (1993). Identification of the von Hippel-Lindau disease tumor suppressor gene. Science, 260, 1317\u20131320. doi:10.1126\/science.8493574","key":"14","DOI":"10.1126\/science.8493574"},{"doi-asserted-by":"crossref","unstructured":"Maher, E.R., Iselius, L., Yates, J.R., Littler, M., Benjamin, C., Harris, R., . . . Morton, N. (1991). Von Hippel-Lindau disease: A genetic study. Journal of Medical Genetics, 28, 443\u2013447. doi:10.1136\/jmg.28.7.443","key":"15","DOI":"10.1136\/jmg.28.7.443"},{"doi-asserted-by":"crossref","unstructured":"Maher, E.R., Neumann, H.P., & Richard, S. (2011). Von Hippel-Lindau disease: A clinical and scientific review. European Journal of Human Genetics, 19, 617\u2013623. doi:10.1038\/ejhg.2010.175","key":"16","DOI":"10.1038\/ejhg.2010.175"},{"doi-asserted-by":"crossref","unstructured":"Maher, E.R., Yates, J.R., Harries, R., Benjamin, C., Harris, R., Moore, A.T., & Ferguson-Smith, M.A. (1990). Clinical features and natural history of von Hippel-Lindau disease. Quarterly Journal of Medicine, 77, 1151\u20131163. doi:10.1093\/qjmed\/77.2.1151","key":"17","DOI":"10.1093\/qjmed\/77.2.1151"},{"doi-asserted-by":"crossref","unstructured":"Mahon, S.M., & Waldman, L. (2012). Von Hippel-Lindau syndrome: Implications for nursing care. Oncology Nursing Forum, 39, 533\u2013536. doi:10.1188\/12.ONF.533-536","key":"18","DOI":"10.1188\/12.ONF.533-536"},{"unstructured":"Molino, D., Sepe, J., Anastasio, P., & De Santo, N.G. (2006). The history of von Hippel-Lindau disease. Journal of Nephrology, 19 (Suppl. 10), S119\u2013S123.","key":"19"},{"unstructured":"National Cancer Institute. (2015). Major heritable renal cell cancer syndromes. Retrieved from http:\/\/www.cancer.gov\/cancertopics\/pdq\/genetics\/kidney\/HealthProfessional\/page2#Section_29","key":"20"},{"unstructured":"NYU Langone Medical Center. (2015). Von Hippel-Lindau disease. Retrieved from http:\/\/nyulangone.org\/conditions\/von-willebrand-disease","key":"21"},{"doi-asserted-by":"crossref","unstructured":"Petersen, G.M. (2000). Genetic testing. Hematology\/Oncology Clinics of North America, 14, 939\u2013952. doi:10.1016\/S0889-8588(05)70320-8","key":"22","DOI":"10.1016\/S0889-8588(05)70320-8"},{"doi-asserted-by":"crossref","unstructured":"Puataweepong, P., Dhanachai, M., Hansasuta, A., Dangprasert, S., Sitathanee, C., Puddhikarant, P., . . . Pairat, K. (2014). The clinical outcome of intracranial hemangioblastomas treated with linac-based stereotactic radiosurgery and radiotherapy. Journal of Radiation Research, 55, 761\u2013768. doi:10.1093\/jrr\/rrt235","key":"23","DOI":"10.1093\/jrr\/rrt235"},{"doi-asserted-by":"crossref","unstructured":"Sadowski, S.M., Weisbrod, A.B., Ellis, R., Patel, D., Alimchandani, M., Quezado, M., . . . Kebebew, E. (2014). Prospective evaluation of the clinical utility of 18-fluorodeoxyglucose PET CT scanning in patients with von Hippel-Lindau-associated pancreatic lesions. Journal of the American College of Surgeons, 218, 997\u20131003. doi:10.1016\/j.jamcollsurg.2014.01.004","key":"24","DOI":"10.1016\/j.jamcollsurg.2014.01.004"},{"doi-asserted-by":"crossref","unstructured":"Sarangi, S., Lanikova, L., Kapralova, K., Acharya, S., Swierczek, S., Lipton, J.M., . . . Prchal, J.T. (2014). The homozygous VHLD126N missense mutation is associated with dramatically elevated erythropoietin levels, consequent polycythemia, and early onset severe pulmonary hypertension. Pediatric Blood and Cancer, 61, 2104\u20132106. doi:10.1002\/pbc.25056","key":"25","DOI":"10.1002\/pbc.25056"},{"doi-asserted-by":"crossref","unstructured":"Sardi, I., Sanzo, M., Giordano, F., Buccoliero, A.M., Mussa, F., Aric\u00f3, M., & Genitori, L. (2009). Monotherapy with thalidomide for treatment of spinal cord hemangioblastomas in a patient with von Hippel-Lindau disease. Pediatric Blood and Cancer, 53, 464\u2013467. doi:10.1002\/pbc.22065","key":"26","DOI":"10.1002\/pbc.22065"},{"doi-asserted-by":"crossref","unstructured":"Stolle, C., Glenn, G., Zbar, B., Humphrey, J.S., Choyke, P., Walther, M., . . . Linehan, W.M. (1998). Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Human Mutation, 12, 417\u2013423.","key":"27","DOI":"10.1002\/(SICI)1098-1004(1998)12:6<417::AID-HUMU8>3.0.CO;2-K"},{"doi-asserted-by":"crossref","unstructured":"Tomasic, N.L., Piterkova, L., Huff, C., Bilic, E., Yoon, D., Miasnikova, G.Y., . . . Prchal, J.T. (2013). The phenotype of polycythemia due to Croatian homozygous VHL (571C>G:H191D) mutation is different from that of Chuvash polycythemia (VHL 598C>T:R200W). Haematologica, 98, 560\u2013567. doi:10.3324\/haematol.2012.070508","key":"28","DOI":"10.3324\/haematol.2012.070508"},{"unstructured":"U.S. National Library of Medicine. (2012). Von Hippel-Lindau syndrome. Retrieved from http:\/\/ghr.nlm.nih.gov\/condition\/von-hippel-lindau-syndrome","key":"29"},{"doi-asserted-by":"crossref","unstructured":"Wilding, A., Ingham, S.L., Lalloo, F., Clancy, T., Huson, S.M., Moran, A., & Evans, D.G. (2012). Life expectancy in hereditary cancer predisposing diseases: An observational study. Journal of Medical Genetics, 49, 264\u2013269. doi:10.1136\/jmedgenet-2011-100562","key":"30","DOI":"10.1136\/jmedgenet-2011-100562"},{"doi-asserted-by":"crossref","unstructured":"Zhang, C., Yang, A.I., Vasconcelos, L., Moon, S., Yang, C., Nesvick, C.L., . . . Zaghloul, K.A. (2014). Von Hippel-Lindau disease associated pulmonary carcinoid with cranial metastasis. Journal of Clinical Endocrinology and Metabolism, 99, 2633\u20132636.","key":"31","DOI":"10.1210\/jc.2014-1732"},{"doi-asserted-by":"crossref","unstructured":"Zhang, S., Zhou, X., Wang, B., Zhang, K., Liu, S., Yue, K., . . . Wang, X. (2014). Loss of VHL expression contributes to epithelial-mesenchymal transition in oral squamous cell carcinoma. Oral Oncology, 50, 809\u2013817. doi:10.1016\/j.oraloncology.2014.06.007","key":"32","DOI":"10.1016\/j.oraloncology.2014.06.007"}],"container-title":["Clinical Journal of Oncology Nursing"],"original-title":[],"link":[{"URL":"http:\/\/cjon.ons.org\/cjon\/19\/6\/von-hippel-lindau-current-evidence-diagnosis-treatment-and-nursing-implications","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:53:01Z","timestamp":1763754781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ons.org\/publications-research\/cjon\/19\/6\/von-hippel-lindau-current-evidence-diagnosis-treatment-and-nursing"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,1]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12,1]]}},"URL":"https:\/\/doi.org\/10.1188\/15.cjon.e121-e125","relation":{},"ISSN":["1092-1095","1538-067X"],"issn-type":[{"type":"print","value":"1092-1095"},{"type":"electronic","value":"1538-067X"}],"subject":[],"published":{"date-parts":[[2015,12,1]]}}}